Tyrosinaemia screening implemented in England
Newborn screening for hereditary tyrosinaemia type 1 (HT1) has been implemented in England.
Search results for about
Behind the scenes with the UK NSC’s Research and Methodology Group
The UK NSC’s Research and Methodology Group has advised on a wide range of screening research projects since its launch.
UK NSC moves to 2-yearly open call cycle
UK NSC is moving to a 2-yearly cycle for inviting stakeholders to submit new screening topic proposals.
Partnership board updated on work to review evidence for SMA newborn screening
The SMA screening ISE partnership board was updated on a range of activities at its most recent meeting.
Exciting opportunities to join UK NSC expert groups
The UK NSC has 15 vacancies to fill on 3 of its expert advisory groups.
In-service evaluation in screening programmes
The UK NSC evidence review process guidance has been updated with an expanded definition of in-service evaluation.
UK NSC publishes SMA screening evidence documents
The UK NSC has published a suite of documents relating to the review of evidence on newborn screening for spinal muscular atrophy.
UK NSC consults on extending the in-service evaluation of screening for SCID
Posted by:
Mike Harris, Posted on:
-
Categories:
Newborn Blood Spot Screening, UK National Screening Committee
The UK National Screening Committee has opened a consultation on a recommendation to continue the in-service evaluation of newborn screening for SCID in NHS services.
Feedback invited on UK NSC’s work on additional breast screening for women with dense breasts
The UK NSC is seeking feedback on evidence relating to additional breast screening for women with dense breasts.
Norwegian lung cancer screening delegation visit
A team of clinicians and experts from Norway visited England to learn about the NHS Lung Cancer Screening Programme.